Indoco Remedies Ltd
NSE:INDOCO
Indoco Remedies Ltd
NSE:INDOCO
Price:
164
INR
-5.45%
Market Cap:
₹15.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Indoco Remedies Ltd
NSE:INDOCO
|
IN |
|
G
|
Grupo Supervielle SA
BCBA:SUPV
|
AR |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
Actual Experience PLC
LSE:ACT
|
UK |
Cash Flow Statement
Cash Flow Statement
Indoco Remedies Ltd
Indoco Remedies Ltd
Currency: INR
| Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
1 320
|
1 974
|
2 366
|
2 260
|
0
|
0
|
1 243
|
1 264
|
(754)
|
(1 271)
|
|
| Depreciation & Amortization |
731
|
771
|
790
|
730
|
706
|
761
|
919
|
1 069
|
1 138
|
1 194
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
7
|
0
|
29
|
0
|
22
|
0
|
|
| Other Non-Cash Items |
366
|
249
|
82
|
(153)
|
503
|
844
|
572
|
765
|
708
|
873
|
|
| Cash Taxes Paid |
197
|
284
|
411
|
680
|
617
|
473
|
295
|
176
|
171
|
54
|
|
| Cash Interest Paid |
232
|
217
|
150
|
184
|
272
|
309
|
361
|
507
|
639
|
855
|
|
| Change in Working Capital |
(1 595)
|
(1 585)
|
(1 499)
|
(1 119)
|
(1 348)
|
(1 736)
|
(1 173)
|
(70)
|
(143)
|
612
|
|
| Cash from Operating Activities |
822
N/A
|
1 409
+71%
|
1 738
+23%
|
1 718
-1%
|
1 788
+4%
|
1 442
-19%
|
1 560
+8%
|
2 226
+43%
|
949
-57%
|
1 408
+48%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(769)
|
(1 134)
|
(1 253)
|
(1 618)
|
(2 073)
|
(2 353)
|
(4 260)
|
(5 296)
|
(3 562)
|
(2 368)
|
|
| Other Items |
102
|
37
|
39
|
(52)
|
(9)
|
174
|
(65)
|
(88)
|
170
|
651
|
|
| Cash from Investing Activities |
(667)
N/A
|
(1 097)
-64%
|
(1 214)
-11%
|
(1 670)
-38%
|
(2 082)
-25%
|
(2 179)
-5%
|
(4 325)
-98%
|
(5 383)
-24%
|
(3 391)
+37%
|
(1 718)
+49%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
16
|
0
|
|
| Net Issuance of Debt |
(39)
|
(162)
|
(156)
|
372
|
707
|
1 871
|
3 365
|
3 372
|
3 176
|
1 123
|
|
| Cash Paid for Dividends |
(28)
|
(28)
|
(138)
|
(138)
|
(207)
|
(398)
|
(207)
|
(144)
|
(139)
|
(30)
|
|
| Other |
(232)
|
(217)
|
(150)
|
(184)
|
(272)
|
(309)
|
(361)
|
(507)
|
(639)
|
(855)
|
|
| Cash from Financing Activities |
(299)
N/A
|
(406)
-36%
|
(444)
-9%
|
50
N/A
|
228
+359%
|
1 164
+411%
|
2 804
+141%
|
2 729
-3%
|
2 414
-12%
|
254
-89%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
(143)
N/A
|
(94)
+35%
|
81
N/A
|
97
+21%
|
(65)
N/A
|
427
N/A
|
39
-91%
|
(428)
N/A
|
(28)
+94%
|
(55)
-100%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
54
N/A
|
276
+413%
|
485
+76%
|
100
-79%
|
(284)
N/A
|
(911)
-221%
|
(2 700)
-196%
|
(3 070)
-14%
|
(2 612)
+15%
|
(960)
+63%
|
|
Switch to:
Switch to:
See Also
Discover More
